In an era where equality is championed across various sectors, the medical field remains conspicuously behind. Despite advancements, women continue to face significant disparities in healthcare—a reflection of deep-rooted biases and systemic oversights that demand critical examination.

The foundation of modern medicine is built upon research that has historically marginalised women. For decades, clinical trials predominantly featured male participants, with findings generalised to the entire population. This exclusion was often justified by concerns over hormonal fluctuations in women complicating results or potential risks to fertility. However, this male-centric approach has led to a significant data gap, adversely affecting women’s health outcomes. A systematic scoping review highlighted that this male bias in medical research has led to real-life disadvantages for female patients, emphasising the need for more inclusive studies.

The repercussions of this bias are evident in diagnostic processes. Women often report that their symptoms are dismissed or attributed to psychological causes. A survey conducted in early 2019 found that more than half of women, compared with one-third of men, believe gender discrimination in patient care is a serious problem. One in five women felt that a healthcare provider had ignored or dismissed their symptoms. This scepticism towards women’s health complaints can lead to dire outcomes. Conditions like endometriosis, which affects approximately 10% of women globally, often go undiagnosed for years, causing unnecessary suffering and complications.

The underrepresentation of women in medical research has resulted in a significant data gap. As recently as 2019, women accounted for roughly 40% of participants in clinical trials for diseases that most affect them, such as cancer, cardiovascular disease, and psychiatric disorders, despite representing 51% of the U.S. population. This lack of representation means that medical guidelines are often based on data that doesn’t fully account for female physiology, leading to less effective treatments for women.

Maternal health statistics further underscore the disparities. The United States has the highest rate of maternal death among developed nations, with significant racial disparities and large differences in rates between states. These alarming figures highlight systemic issues in healthcare access, quality of care, and socioeconomic factors that disproportionately affect women, particularly women of colour.

Mental health is another area where women face disparities. Women are more likely to experience certain mental health conditions, such as depression and anxiety, yet they often encounter barriers to effective treatment. Societal stigmas, underfunding of mental health services, and a lack of research into gender-specific treatments contribute to this gap.

Addressing these disparities requires a comprehensive and systemic policy approach that encompasses research, education, clinical practice, and broader healthcare infrastructure. Governments must mandate equal representation of women in clinical trials through stringent regulatory frameworks and funding incentives, ensuring that sex-based physiological differences are accounted for in medical research. This includes enforcing penalties for non-compliance and establishing funding streams specifically dedicated to investigating conditions that disproportionately or uniquely affect women.

Medical education must be restructured to integrate gender-specific health considerations into curricula, requiring comprehensive training on the physiological, psychological, and social determinants of women’s health. This should extend beyond specialist fields and be embedded into general medical, nursing, and allied healthcare training. Ongoing professional development programmes must reinforce these principles, ensuring that clinicians are equipped to identify and address gender disparities in real-world practice.

Healthcare delivery systems should be reformed to include mandatory gender-sensitivity training for medical professionals, ensuring that implicit biases do not undermine diagnostic accuracy or quality of care. Institutions should implement accountability measures, such as patient feedback systems and independent audits, to monitor gender bias in clinical interactions. Additionally, financial incentives should be introduced to encourage healthcare providers to prioritise conditions that disproportionately affect women, ensuring that funding is not solely directed towards diseases with higher commercial viability.

To combat systemic inequities in maternal healthcare, governments must invest in strengthening perinatal services, particularly in underserved communities. This includes expanding access to midwifery-led care, increasing funding for community-based maternal health initiatives, and developing targeted intervention programmes for high-risk populations. Policies should also focus on reducing racial disparities in maternal outcomes through anti-discrimination frameworks and culturally competent healthcare models.

Mental health services must be integrated into primary healthcare settings to ensure that gender-specific mental health needs are met efficiently. Governments must allocate targeted funding for mental health research that explores the intersection of gender, socioeconomic status, and access to care. Insurance policies should be revised to mandate comprehensive mental health coverage, removing financial barriers that disproportionately affect women, particularly those from low-income backgrounds.

At an international level, policymakers must push for the decolonisation of global health initiatives, ensuring that women’s health strategies are not dictated by Western-centric priorities but instead reflect the needs and voices of diverse populations. Funding models should shift away from donor-driven agendas towards locally led research and policy development, allowing low- and middle-income countries to exercise greater agency in shaping their healthcare systems.

The structural inequalities embedded within healthcare are not incidental but the product of centuries of systemic neglect. Addressing these issues requires more than incremental reforms; it demands a radical reimagining of how healthcare is researched, taught, and delivered. Without decisive political will and coordinated global action, the gender gap in healthcare will persist, continuing to jeopardise the health and well-being of half the world’s population.